Overview
Background
Professor Susan Tett is a registered pharmacist with research interests in Quality Use of Medicines (improving how medicines are used) and clinical pharmacokinetics (optimising medicine doses)
Sue completed her PhD in 1988. Since this time she has been in research positions and in academia at Sydney University, St Vincent’s Hospital, Sydney and at the University of Queensland. She has over 150 peer reviewed research publications and over 200 conference presentations and is on Editorial Board of Clinical Pharmacokinetics. Sue was Head of the School of Pharmacy, University of Queensland 1996-2004 and Deputy Executive Dean & Associate Dean Research for the Faculty of Health Sciences 2006-2010, including periods as Acting Executive Dean.
Susan Tett has been a member of many Australian national and State advisory committees, including Pharmaceutical Health and Rational use of Medicines Committee 1996-2004, Pharmaceutical Sub-Committee of the Australian Drug Evaluation Committee 1995-2004, Pharmaceutical Industry Working Group 2003-10 , Pharmaceutical Partnerships Program Committee of the Industry Research & Development Board 2003-09, and has participated in NHMRC Project Grant Review Panels and Fellowships Panels. She was also Councillor for the Pharmaceutical Society of Australia (Queensland Branch) and was the Australian Pharmacist of the Year in 1999, for her contributions to pharmacy education and research.
Sue’s research interests are directed towards optimising the clinical use of medications. General areas of research include quality use of medicines, clinical pharmacokinetics and pharmacodynamics. Sue supervises a number of postgraduate students and is actively involved in innovation in the pharmacy profession, pushing the professional boundaries. She is committed to enhancing the role of the health care team in optimising consumer health outcomes.
Availability
- Emeritus Professor Sue Tett is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor (Honours), University of Sydney
- Doctor of Philosophy, University of Sydney
Research interests
-
Clinical pharmacokinetics and pharmacodynamics
Many projects being undertaken to define better dosing options to give improved patient outcomes - eg. in people who have received organ transplants (tacrolimus, mycophenolate, sirolimus) or who need other immunosuppressants (eg. leflunomide in people with rheumatoid arthritis).
-
Quality use of Medicines
Numerous projects designed to improve how medicines are used - particular interests in health care teams, including consumers; rural health; medication use and misuse and international comparisons of prescription medication use
Works
Search Professor Sue Tett’s works on UQ eSpace
Featured
2013
Journal Article
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
Abd Rahman, Azrin N., Tett, Susan E. and Staatz, Christine E. (2013). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Clinical Pharmacokinetics, 52 (5), 303-331. doi: 10.1007/s40262-013-0039-8
Featured
2013
Journal Article
Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada
Tett, Susan E., Sketris, Ingrid, Cooke, Charmaine, Velhuyzen van Zanten, Sander and Barozzi, Nadia (2013). Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada. Pharmacoepidemiology and Drug Safety, 22 (7), 735-743. doi: 10.1002/pds.3442
Featured
2011
Journal Article
Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?
Staatz, Christine E. and Tett, Susan E. (2011). Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?. Clinical Pharmacokinetics, 50 (12), 759-772. doi: 10.2165/11596380-000000000-00000
Featured
2011
Journal Article
Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure
Tett, Susan E., Saint-Marcoux, Franck, Staatz, Christine E., Brunet, Merce, Vinks, Alexander A., Miura, Masatomo, Marquet, Pierre, Kuypers, Dirk R., van Gelder, Teun and Cattaneo, Dario (2011). Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplantation Reviews, 25 (2), 47-57. doi: 10.1016/j.trre.2010.06.001
Featured
2011
Journal Article
How is medication prescribing ceased? A systematic review
Ostini, Remo, Jackson, Claire, Hegney, Desley and Tett, Susan E. (2011). How is medication prescribing ceased? A systematic review. Medical Care, 49 (1), 24-36. doi: 10.1097/MLR.0b013e3181ef9a7e
Featured
2009
Journal Article
The Australian rise of esomeprazole-was expenditure on samples a contributor?
Kyle, G. J., Nissen, L. M. and Tett, S. E. (2009). The Australian rise of esomeprazole-was expenditure on samples a contributor?. Pharmacoepidemiology and Drug Safety, 18 (1), 62-68. doi: 10.1002/pds.1685
Featured
2009
Journal Article
Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing
Barozzi, N. and Tett, S. E. (2009). Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing. Clinical Therapeutics, 31 (4), 849-861. doi: 10.1016/j.clinthera.2009.04.012
Featured
2008
Journal Article
Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use
Ostini, R., Hegney, D., Mackson, J. M., Williamson, M and Tett, S.E. (2008). Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use. Pharmacoepidemiology and Drug Safety, 17 (11), 1077-1090. doi: 10.1002/pds.1638
Featured
2008
Journal Article
A comparison of benzodiazepine and related drug use in Nova Scotia and Australia
Smith, Alesha J., Sketris, Ingrid, Cooke, Charmaine, Gardner, David, Kisely, Steve and Tett, Susan E. (2008). A comparison of benzodiazepine and related drug use in Nova Scotia and Australia. The Canadian Journal of Psychiatry, 53 (8), 545-552. doi: 10.1177/070674370805300809
2020
Journal Article
Evaluation of Bayesian forecasting methods for prediction of tacrolimus exposure using samples taken on two occasions in adult kidney transplant recipients
Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2020). Evaluation of Bayesian forecasting methods for prediction of tacrolimus exposure using samples taken on two occasions in adult kidney transplant recipients. Therapeutic Drug Monitoring, 43 (2), 238-246. doi: 10.1097/ftd.0000000000000814
2019
Journal Article
Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients
Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2019). Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients. Clinical Drug Investigation, 39 (12), 1175-1184. doi: 10.1007/s40261-019-00844-y
2019
Journal Article
Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients
Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2019). Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients. Therapeutic Drug Monitoring, 41 (6), 755-760. doi: 10.1097/FTD.0000000000000687
2019
Conference Publication
Saliva prednisolone measurements in adult kidney transplant recipients
Staatz, C. E., Tett, S. E., Isbel, N., Mc Whinney, B. and Brooks, E. (2019). Saliva prednisolone measurements in adult kidney transplant recipients. International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Foz de Iguassu, Brazil, September 2019.
2018
Journal Article
Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?
Gardiner, Kyle M., Tett, Susan E. and Staatz, Christine E. (2018). Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?. Drugs in R & D, 18 (4), 271-282. doi: 10.1007/s40268-018-0254-8
2018
Journal Article
Psychiatric adverse events in oseltamivir prophylaxis trials: novel comparative analysis using data obtained from clinical study reports
Jones, Mark, Tett, Susan E. and Del Mar, Chris (2018). Psychiatric adverse events in oseltamivir prophylaxis trials: novel comparative analysis using data obtained from clinical study reports. Pharmacoepidemiology and Drug Safety, 27 (11), 1217-1222. doi: 10.1002/pds.4651
2018
Journal Article
Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients
Brooks, Emily K, Staatz, Christine E, Tett, Susan E, Isbel, Nicole M and McWhinney, Brett (2018). Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients. Therapeutic Drug Monitoring, 40 (2), 195-201. doi: 10.1097/FTD.0000000000000486
2018
Conference Publication
Evaluation of multiple linear regression limited sampling strategies for enteric-coated mycophenolate sodium in adult kidney transplant recipients.
Brooks, E., Tett, S. E., Isbel, N. M., McWhinney, B. and Staatz, C. E. (2018). Evaluation of multiple linear regression limited sampling strategies for enteric-coated mycophenolate sodium in adult kidney transplant recipients.. American Transplant Congress, Seattle, WA United States, 2-6 June 2018. Hoboken, NJ United States: Wiley.
2018
Conference Publication
Saliva prednisolone in adult kidney transplant recipients receiving triple therapy with tacrolimus, mycophenolate sodium and prednisolone
Brooks, E., Tett, S. E., Isbel, N. and Staatz, C. E. (2018). Saliva prednisolone in adult kidney transplant recipients receiving triple therapy with tacrolimus, mycophenolate sodium and prednisolone. RACP Trainee Research Awards, Brisbane, QLD Australia, 7 November 2018.
2018
Conference Publication
Saliva mycophenolic acid monitoring following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients.
Brooks, E., Tett, S. E., Isbel, N. M., McWhinney, B. and Staatz, C. E. (2018). Saliva mycophenolic acid monitoring following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients.. International Association of Therapeutic Drug Monitoring and Clinical Toxicology Brisbane, Brisbane, QLD Australia, 16-19 September 2018.
2017
Journal Article
Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis
Abd Rahman, Azrin N, Tett, Susan E, Abdul Gafor, Halim A, McWhinney, Brett C and Staatz, Christine E (2017). Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis. European journal of drug metabolism and pharmacokinetics, 42 (6), 993-1004. doi: 10.1007/s13318-017-0420-3
Funding
Past funding
Supervision
Availability
- Emeritus Professor Sue Tett is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Towards optimal dosing of new immunosuppressant drugs in solid organ transplants
Improving dosing of immunosuppressant medications in people who have received solid organ transplants. Studies with tacrolimus, mycophenolate or sirolimus can be offered
-
International comparisons of medicines use, investigating pharmaceutical policy and other influences on usage
International comparisons of the use of prescription medicines are important to improve the quality use of medicines across different jurisdictions. Lessons learned from one area can be translated into interventions to be applied to improve medicine use across a number of different health care systems
-
Factors affecting prescribing and use of medicines, including the influence of various marketing strategies (eg. free prescription medicine samples), the influence of location (eg. rural, remote) and
Many factors are know to affect prescribing and use of medicines. Projects in this area will be designed to investigate specific aspects of these factors eg. effects of remote location, influence of free sample medications etc etc
-
Drug usage evaluation across different jurisdictions
Drug usage evaluation, including the feedback, intervention and re-evaluation stages can influence how medicines are prescribed and used. Multicentre studies can have wide ranging influence, and studies across several jurisdictions (eg. hospital/community; public/private) can influence quality use of medicines in sustainable ways across large geographical areas. Projects are offered in the areas, particularly focussing on multi-disciplinary teams and multi-jurisdictional influences
-
Population Pharmacokinetics and Pharmacodynamics of the Newer Immunosuppressant Drug
Supervision history
Completed supervision
-
2009
Doctor Philosophy
Geographical differences, national and international, in the utilization of the benzodiazepine and antidepressant groups of medicines
Principal Advisor
Other advisors: Emeritus Professor Wayne Hall
-
2007
Doctor Philosophy
CONVENTIONAL MEDICINE AND COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) - CONCORDANCE AND PERSPECTIVES OF CONSUMERS, HEALTH PROFESSIONALS AND CAM PRACTITIONERS
Principal Advisor
-
2005
Doctor Philosophy
Use of leflunomide in rheumatoid arthritis
Principal Advisor
-
2004
Doctor Philosophy
Pharmacokinetic studies with sirolimus and tacrolimus
Principal Advisor
-
2002
Doctor Philosophy
POPULATION PHARMACOKINETICS AND PHARMOCODYNAMICS OF THE NEW IMMUNOSUPRESSANT DRUGS
Principal Advisor
-
2002
Doctor Philosophy
QUALITY USE OF MEDICINES: FROM DUE TO RURAL COMMUNITY PHARMACY PRACTICE
Principal Advisor
Other advisors: Emeritus Professor Maree Smith
-
2021
Doctor Philosophy
Evaluating Prediction Methods for Estimating Tacrolimus, Mycophenolate and Prednisolone Exposure Following Adult Kidney Transplantation
Associate Advisor
Other advisors: Dr Christine Staatz
-
2016
Doctor Philosophy
Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
Associate Advisor
Other advisors: Dr Christine Staatz
-
2009
Doctor Philosophy
Prescription medicine samples and therapy initiation. Developing a best practice system with community pharmacists in Australia
Associate Advisor
Other advisors: Professor Lisa Nissen
-
2007
Doctor Philosophy
Optimising the assesssment of renal function and determining the renal elimination of drugs using various methodologies
Associate Advisor
Media
Enquiries
Contact Emeritus Professor Sue Tett directly for media enquiries about:
- Clinical pharmacokinetics
- Clinical pharmacy
- Medicine - quality use of
- Pharmacokinetics
- Pharmacy - clinical
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: